CLINICAL_TRIALS
trial_result
· 2024-03-20
Clinical Trial Update: Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety [Phase 2]
Summary
Phase 2 trial evaluating VQW-765 versus placebo for performance anxiety has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanda Pharmaceuticals | Conditions: Performance Anxiety | Phase 2 | Status: COMPLETED